Pancreatic Cancer | Clinical Trials :: Cancer Center :: SOMC
- RTOG 0848 (SOMC Pending)– Phase III Trial Evaluating both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (Arm 2 Closed to Accrual)
- ECOG E2211– Phase II Randomized Study of Temozolomide or Temozolomide and Cepecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
- SWOG S1505– A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
- ECOG EA2142– A Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropanceatic Neuroendocrine Carcinomas
tags, as close as possible to the opening tag.
Creation Date: 08/12/2015